Benefits of Formalized Care Support Program Following Acute Leukemia Diagnosis
ConditionAcute Leukemia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age26-80
SponsorCentre Henri Becquerel
About this trial
The purpose of this study is to determine the impact on anxiety between patients with a period of care support following their announcement of an acute leukemia (AL) diagnosis and patients without this accompaniment.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
informed consent signed
medical confirmation of acute leukemia diagnosis
age equal of superior to 26 years and under 80 years
confirmed diagnosis not yet treated
Disqualifiers
-Patient unable to understand the study for any reason or to comply with the trial's requirements
Patient in relapse of acute leukemia
Patient diagnosed with acute myeloid leukemia 3
History of cancer within the 5 years preceding the year of study enrollment
Trial design
Design model
Parallel
Treatments tested in this trial
care support program after diagnosis announcement
Other interventiona dedicated time with a specialized nurse in announcement will be given tot the patient. The anxiety will also be evaluated
Treatment groups
110 Participants
are divided into 2 treatment groupsGroup A: Standard armNo intervention 0 interventions
Group B: Experimental armExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Anxiety improvment
variation of anxiety level using STAI questionnaire
Time frame
7 days after diagnosis announcementSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov